In The News
The Scientist | December 01, 2017
# 5 Quanterix | SR-X Ultra-Sensitive Biomarker Detection System
SelectScience | November 30, 2017
Kevin Hrusovsky is President and CEO of Quanterix, a company that is developing an ultrasensitive immunoassay platform that is capable of detecting very low levels of biomarkers in the body. Watch this exclusive interview to discover Hrusovsky’s vision for the future of healthcare.
Alzforum | November 17, 2017
Serum NfL levels rise before symptoms appear in familial AD. NfL correlates with cognitive decline and brain atrophy. In MS patients, NfL levels drop with treatment.
July 23, 2015
The Washington Post Read the article at www.washingtonpost.com.
July 31, 2015
Lexington Minuteman Read the article at www.wickedlocal.com.
Quanterix, The NFL-Backed Neurological Testing System, On Verge Of Breakthroughs In Concussion Detection
October 11, 2015
Sport Techie Read the article at www.sporttechie.com.